Related Experiment Video
Updated: Apr 23, 2026

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.2K
A transcriptomic-based model associated with PARP inhibitor sensitivity and immunogenic signatures in ovarian cancer
Xinxin Sun1, Cancan Li1, Zhihong Wang1
1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, Henan, China.
Discover Oncology
|April 21, 2026
Abstract
No abstract available in PubMed .

